This is a StreetInsider.com Premium Only Page

(ORTX) – StreetInsider.com Reports

Dec 11, 2023 07:18 AM Orchard Therapeutics (ORTX) Receives Swissmedic Approval for Libmeldy in Early-onset MLD

Nov 30, 2023 07:00 AM Orchard Therapeutics (ORTX) Receives U.S. FDA Fast Track Designation for OTL-203 in MPS-IH

Oct 5, 2023 08:35 AM Stifel Downgrades Orchard Therapeutics (ORTX) to Hold Following Acqusition

Oct 5, 2023 04:55 AM Orchard Therapeutics Plc (ORTX) option implied volatility into share price move up

Oct 5, 2023 04:44 AM Orchard Therapeutics (ORTX) Acquired by Kyowa Kirin for $16/sh Cash plus $1 CVR

Sep 18, 2023 07:02 AM Orchard Therapeutics (ORTX) Announces Acceptance of Biologics License Application for OTL-200 in MLD and Receives Priority Review

Aug 10, 2023 05:04 PM Orchard Therapeutics Plc (ORTX) Announces 20.83M ADRs Offering by Selling Stockholders

Aug 3, 2023 08:51 AM Orchard Therapeutics Plc (ORTX) Tops Q2 EPS by 196c

Aug 3, 2023 07:01 AM Orchard Therapeutics Plc (ORTX) Completes Submission of BLA for OTL-200 in MLD to U.S. FDA

Jun 26, 2023 07:08 AM Orchard Therapeutics (ORTX) Announces Second Closing of Strategic Financing, Resulting in $34 Million of Additional Capital

Jun 13, 2023 07:23 AM Orchard Therapeutics (ORTX) PT Lowered to $34 at Oppenheimer

May 19, 2023 09:01 AM Orchard Therapeutics (ORTX) Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT

May 15, 2023 09:10 AM Key Biotech Events to Watch, Week of 5/15/2023

May 15, 2023 09:08 AM Weekly biotech pulse: X4 Pharma data on deck, AbbVie set for FDA review

May 3, 2023 07:03 AM Orchard Therapeutics Plc (ORTX) Presents New Clinical and Pre-clinical Data

Mar 28, 2023 06:36 AM Orchard Therapeutics (ORTX) PT Raised to $15 at Cantor Fitzgerald

Mar 14, 2023 04:27 PM Orchard Therapeutics (ORTX) PT Raised to $22 at Stifel

Mar 13, 2023 08:16 AM Orchard Therapeutics (ORTX) PT Raised to $37 at Oppenheimer

Mar 6, 2023 06:21 AM Orchard Therapeutics Plc (ORTX) Tops Q4 EPS by 15c

Mar 6, 2023 06:06 AM Orchard Therapeutics (ORTX) Issues Business Update, Reports FY22 Results

Mar 6, 2023 06:03 AM Orchard Therapeutics Plc (ORTX) Enters Up to $188M Strategic Financing

Feb 27, 2023 07:01 AM Orchard Therapeutics Plc (ORTX) Enters Agreement Enabling Reimbursed Access to Libmeldy for All Eligible MLD Patients in Sweden

Feb 24, 2023 07:05 AM Orchard Therapeutics Plc (ORTX) Announces Presentation of Updated Integrated Analysis of OTL-200 in MLD and Reports Progress with Newborn Screening Efforts

Feb 10, 2023 07:02 AM Orchard Therapeutics Plc (ORTX) Announces Proposed ADS Ratio Change

Jan 5, 2023 07:01 AM Orchard Therapeutics (ORTX) Granted FDA Clearance of IND Application for OTL-203 in MPS-IH

Dec 13, 2022 08:14 AM Orchard Therapeutics (ORTX) PT Lowered to $4 at Stifel

Dec 1, 2022 07:01 AM Orchard Therapeutics (ORTX) Announces Swissmedic Validation of the Marketing Authorization Application for Libmeldy

Nov 14, 2022 07:06 AM Orchard Therapeutics Plc (ORTX) Misses Q3 EPS by 14c

Oct 6, 2022 04:43 PM Orchard Therapeutics Plc (ORTX) Announces $30M At-the-market Equity Program

Sep 19, 2022 08:03 AM Viracta Therapeutics (VIRX) Announces Chief Executive Officer Leadership Succession

Jul 18, 2022 09:17 AM Oppenheimer Assumes Orchard Therapeutics (ORTX) at Outperform

Jun 15, 2022 06:43 AM Orchard Therapeutics (ORTX) NDR Takeaways - Stifel

May 13, 2022 05:50 AM Orchard Therapeutics (ORTX) PT Lowered to $4 at Barclays

Apr 11, 2022 07:00 AM Orchard Therapeutics Plc (ORTX) Announces Reimbursement Agreement Making Libmeldy Available for All Eligible MLD Patients in Italy

Mar 31, 2022 04:16 PM UPDATE: SMBC Nikko Securities Downgrades Orchard Therapeutics (ORTX) to Neutral

Mar 31, 2022 12:47 PM Orchard Therapeutics (ORTX) PT Lowered to $5 at Stifel

Mar 31, 2022 03:37 AM UPDATE: Cowen Downgrades Orchard Therapeutics (ORTX) to Market Perform

Mar 30, 2022 08:37 AM Orchard Therapeutics Plc (ORTX) Files $200M Mixed Shelf

Mar 30, 2022 07:09 AM Orchard Therapeutics Plc (ORTX) Misses Q4 EPS by 1c

Feb 11, 2022 04:22 PM Stifel Reiterates Buy Rating on Orchard Therapeutics (ORTX), Positive Updates Continue to Reinforce Optimism

Feb 4, 2022 05:39 AM NHS Announcement Paves Way for Orchard's (ORTX) Revenue Generation in England and Wales, but Focus Remains on BLA Submission - Stifel

Jan 21, 2022 07:00 AM Orchard Therapeutics (ORTX) Announces Publication in The Lancet of Long-term Clinical Outcomes with Libmeldy for the Treatment of Children with Early-onset MLD

Jan 12, 2022 06:07 AM 2022 Could Turn the Corner for Orchard Therapeutics Plc (ORTX), Its Programs Could Receive Regulatory Approval - Stifel

Dec 29, 2021 09:56 AM Orchard Therapeutics Plc (ORTX) Ramps 18% on New Buy Rating

Dec 29, 2021 09:24 AM Pre-Open Stock Movers 12/29: (TSP) (DNAY) (ORTX) Higher; (MFIN) (FCEL) (RIVN) Lower (more...)

Dec 29, 2021 08:03 AM Cantor Fitzgerald Assumes Orchard Therapeutics (ORTX) at Overweight, $9 PT

Nov 18, 2021 07:17 AM Orchard Therapeutics (ORTX) Announces NEJM Publication of Interim Proof-of-concept Study Results of OTL-203 for Hurler Syndrome

Nov 16, 2021 03:40 AM UPDATE: JPMorgan Downgrades Orchard Therapeutics (ORTX) to Underweight on Lack of Meaningful Short-term Catalysts and Negative Sentiment

Nov 5, 2021 07:01 AM Orchard Therapeutics (ORTX) PT Lowered to $11 at Wedbush

Nov 5, 2021 05:10 AM Orchard Therapeutics (ORTX) PT Lowered to $13 at Oppenheimer